New York State Common Retirement Fund
NAGE

New York State Common Retirement Fund’s Niagen Bioscience NAGE Stock Holding History

New York State Common Retirement Fund’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2K Hold
3,500
– – ﹤0.01% 3151
2026
Q1 		$15.4K Hold
3,500
– – ﹤0.01% 3044
2025
Q4 		$22.3K Sell
3,500
-13,300
-79% -$92.5K ﹤0.01% 3068
2025
Q3 		$157K Hold
16,800
– – ﹤0.01% 2408
2025
Q2 		$242K Buy
16,800
+13,400
+394% +$132K ﹤0.01% 2173
2025
Q1 		$23.5K Hold
3,400
– – ﹤0.01% 2952
2024
Q4 		$18K Hold
3,400
– – ﹤0.01% 3057
2024
Q3 		$12.4K Sell
3,400
-34,400
-91% -$108K ﹤0.01% 3092
2024
Q2 		$103K Buy
+37,800
New +$126K ﹤0.01% 2771
2022
Q3 		– Sell
-390
Closed -$1K – 3479
2022
Q2 		$1K Sell
390
-19,888
-98% -$38.9K ﹤0.01% 3428
2022
Q1 		$50K Hold
20,278
– – ﹤0.01% 3170
2021
Q4 		$76K Sell
20,278
-88
-0.4% -$475 ﹤0.01% 3145
2021
Q3 		$128K Sell
20,366
-13,639
-40% -$112K ﹤0.01% 3062
2021
Q2 		$335K Buy
34,005
+317
+0.9% +$2.76K ﹤0.01% 2798
2021
Q1 		$315K Hold
33,688
– – ﹤0.01% 2667
2020
Q4 		$162K Hold
33,688
– – ﹤0.01% 2826
2020
Q3 		$135K Hold
33,688
– – ﹤0.01% 2814
2020
Q2 		$155K Hold
33,688
– – ﹤0.01% 2762
2020
Q1 		$110K Hold
33,688
– – ﹤0.01% 2734
2019
Q4 		$145K Sell
33,688
-5,012
-13% -$17.8K ﹤0.01% 2876
2019
Q3 		$152K Hold
38,700
– – ﹤0.01% 2894
2019
Q2 		$180K Buy
38,700
+23,000
+146% +$98.1K ﹤0.01% 2879
2019
Q1 		$66K Hold
15,700
– – ﹤0.01% 3033
2018
Q4 		$54K Hold
15,700
– – ﹤0.01% 3086
2018
Q3 		$67K Hold
15,700
– – ﹤0.01% 3093
2018
Q2 		$58K Buy
+15,700
New +$59.6K ﹤0.01% 3135
2017
Q2 		– Sell
-7,401
Closed -$20K – 3246
2017
Q1 		$20K Buy
7,401
+1
+0% +$3 ﹤0.01% 3117
2016
Q4 		$24K Hold
7,400
– – ﹤0.01% 3100
2016
Q3 		$22K Sell
7,400
-24,200
-77% -$88.9K ﹤0.01% 3118
2016
Q2 		$131K Buy
+31,600
New +$150K ﹤0.01% 2901

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

New York State Common Retirement Fund's NAGE Position: Q2 2026 in Review

New York State Common Retirement Fund held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 3,500 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3151.

New York State Common Retirement Fund first reported a position in NAGE in Q2 2016 and has held it in 30 quarters since. The position peaked at $335K in Q2 2021. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • New York State Common Retirement Fund held 3,500 shares of Niagen Bioscience worth $11.2K as of Q2 2026.
  • New York State Common Retirement Fund left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3151 holding.
  • New York State Common Retirement Fund first reported a position in Niagen Bioscience in Q2 2016 and has held it in 30 quarters since.
  • New York State Common Retirement Fund's Niagen Bioscience position peaked at $335K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.